Bleomycin
Common brands: Bleomycin, Vepesid, Avopef, Etoposide, Doxorubicin Hydrochloride
Top reporter: Fresenius Kabi Usa, Llc
Alkylating Drug [EPC]Topoisomerase Inhibitor [EPC]Corticosteroid [EPC]Platinum-based Drug [EPC]CD20-directed Cytolytic Antibody [EPC]
10,171
Total Reports
4,387
Serious Reports
2,343
Death Reports
30
Reported Reactions
Death Report Ratio: High (23.04%)
Patient Demographics
Reported Adverse Reactions (30)
Side effects reported in FDA adverse event reports for Bleomycin.
| # | Reaction | Reports | % of Total |
|---|---|---|---|
| 1 | FEBRILE NEUTROPENIA | 820 | |
| 2 | OFF LABEL USE | 788 | |
| 3 | NEUTROPENIA | 594 | |
| 4 | DRUG INEFFECTIVE | 500 | |
| 5 | PYREXIA | 459 | |
| 6 | PULMONARY TOXICITY | 410 | |
| 7 | VOMITING | 368 | |
| 8 | NAUSEA | 366 | |
| 9 | ANAEMIA | 355 | |
| 10 | THROMBOCYTOPENIA | 349 | |
| 11 | RESPIRATORY FAILURE | 320 | |
| 12 | SEPSIS | 314 | |
| 13 | ACUTE MYELOID LEUKAEMIA | 304 | |
| 14 | DISEASE PROGRESSION | 291 | |
| 15 | PRODUCT USE IN UNAPPROVED INDICATION | 287 | |
| 16 | DYSPNOEA | 280 | |
| 17 | TOXICITY TO VARIOUS AGENTS | 264 | |
| 18 | PNEUMONIA | 253 | |
| 19 | SECOND PRIMARY MALIGNANCY | 241 | |
| 20 | INTERSTITIAL LUNG DISEASE | 222 | |
| 21 | FATIGUE | 221 | |
| 22 | DEATH | 219 | |
| 23 | PANCYTOPENIA | 213 | |
| 24 | MUCOSAL INFLAMMATION | 206 | |
| 25 | PNEUMONITIS | 202 | |
| 26 | INFECTION | 194 | |
| 27 | NEUROPATHY PERIPHERAL | 194 | |
| 28 | PULMONARY FIBROSIS | 184 | |
| 29 | MYELODYSPLASTIC SYNDROME | 180 | |
| 30 | MALIGNANT NEOPLASM PROGRESSION | 173 |
Important Disclaimer
FDA adverse event reports are submitted voluntarily and do not prove causation. A reported reaction does not mean the drug caused it. Drugs with more users naturally have more reports. Always consult your doctor or pharmacist before making medication decisions.